SAN ANTONIO (Feb. 24, 2011) — Mouse models are yielding important clues about the nature of autism spectrum disorders, which impact an estimated one in 110 children in the U.S.[1] In labs at the UT Health Science Center San Antonio, researchers are studying strains of mice that inherently mimic the repetitive and socially impaired behaviors present in these disorders.
Georgianna Gould, Ph.D., research assistant professor of physiology in the Graduate School of Biomedical Sciences, is eyeing the role that serotonin plays in autism spectrum disorders.
Serotonin is known for giving a sense of well-being and happiness. It is a neurotransmitter, a chemical that acts like a radio tower in the brain conveying signals among cells called neurons. Thirty percent of autism cases may have a serotonin component.[2]
In a recent paper in the Journal of Neurochemistry, Dr. Gould and colleagues showed that a medication called buspirone improved the social behaviors of mice. Buspirone is approved by the U.S. Food and Drug Administration for use in adults as an anti-anxiety and antidepressant adjuvant medication.
Some genetic variations result in diminished transmission of serotonin between neurons. Buspirone increased transmission by partially mimicking the effects of serotonin at cellular sites called receptors.
Reactions to newly encountered mouse
Social interaction behaviors of the mice were measured by placing them in a three-chamber social interaction test and positioning a “stranger” mouse in one of the chambers. Buspirone-treated mice spent more time in the chamber with the stranger mouse than untreated mice and more time sniffing the stranger.
“No animal model is completely characteristic of humans, and we’re far from saying that buspirone is a treatment for behaviors of autistic people,” Dr. Gould said. “But this does offer further proof that serotonin is involved in a significant proportion of autism cases.”
Support from the San Antonio Area Foundation made the project possible. Co-authors of the journal article are Julie Hensler, Ph.D., and Teri Frosto Burke, M.S., of the pharmacology department at the Health Science Center; Lynette Daws, Ph.D., of the university’s physiology department in whose lab the work was conducted; and Robert Benno, Ph.D., and Emmanuel Onaivi, Ph.D., of the biology department at William Paterson University in Wayne, N.J.
2nd serotonin-related avenue
Dr. Gould now plans to study the impact of a diet rich in the amino acid, tryptophan, on the social behavior of the mice. Tryptophan is a biochemical precursor of serotonin, which means it is converted into serotonin during the metabolic process. Foods such as turkey are rich in tryptophan.
“We are going to supplement the diet of mice with tryptophan to see if behavior improves, and also reduce it to see if behavior worsens,” Dr. Gould said. The future study of tryptophan is funded by the Morrison Trust, a San Antonio trust that lists nutrition as one of its topics of interest.
[1] http://www.cdc.gov/ncbddd/autism/data.html#prevalence
[2] http://www.ncbi.nlm.nih.gov/pubmed/21254450
On the Web and Twitter
For current news from the UT Health Science Center San Antonio, please visit our news release website or follow us on Twitter @uthscsa.
About the UT Health Science Center San Antonio
The University of Texas Health Science Center at San Antonio, one of the country’s leading health sciences universities, ranks in the top 3 percent of all institutions worldwide receiving U.S. federal funding. Research and other sponsored program activity totaled $228 million in fiscal year 2010. The university’s schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced approximately 26,000 graduates. The $744 million operating budget supports eight campuses in San Antonio, Laredo, Harlingen and Edinburg. For more information on the many ways “We make lives better®,” visit www.uthscsa.edu.
